HCP Promotions

Most visited topics:
ADA Product Theater Video   >

This 8-minute video is designed to highlight key takeaways from the Corcept Product Theater at the 2023 ADA in San

ADA Video Brochure   >

Video brochure containing both a full and chapterized version of the 2023 ADA Product Theater Video, as well as a

ADA Video Postcard   >

Leave behind postcard with a QR code to drive traffic to the ADA Product Theater Video. FIELD USE: PRINT: Discuss

Adrenal Incidentaloma Biochemical Evaluation Leave Behind   >

One page leave behind outlining the importance of a biochemical evaluation for Adrenal Incidentalomas. Includes how to administer a DST

Aresta Reprint Carrier   >

Provides important key prevalence and risk take aways available in DSE-00932 JUN 2022, the Aresta Reprint “When to Suspect Hidden

Beyond Benign: The Role of Radiologist KAM Leave Behind   >

KAM Use Only: Highlight to Radiologists the importance of evaluating adrenal incidentalomas for hormonal secretions and the importance of referring

Breaking Through Difficult-to-Control T2D: Targeting Hypercortisolism   >

Reprint of article published in The Journal of Family Practice in October 2025. Authors: Pamela Kushner and John Anderson FIELD

CATALYST Flashcard   >

The CATALYST Flashcard is intended to be discussed and is a leave behind for HCPs to showcase the prevalence data

CATALYST Part 1 Reprint   >

Lead Author: Ralph Defronzo BMJ Reprint “Study protocol for a prospective, multicenter study of hypercortisolism in patients with difficult-to-control type

No more resources
Russian DST Patient Instructions
US-DSE-25-0141 01-26
Translated versions of the English DST Patient Instructions. HCPs may share the following translated instructions with patients they have recommended take an overnight dexamethasone suppression test (DST). This resource provides an overview of the test, what to expect and addresses FAQs.

FIELD USE:
  • PRINT: Not approved
  • DIGITAL: May share during In-Person or Remote Meetings through Veeva; May send through Veeva-Approved emails
  • MAIL:Cannot be mailed
Copy Resource Link
Visit Resource Page